Cargando…

KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect †

Kynurenic acid (KYNA) is an endogenous neuroprotective agent of increasing importance. Several derivatives have already been synthesized, bearing an abundance of functional groups attached to the main skeleton in different positions. Several of these compounds have already been tested in biological...

Descripción completa

Detalles Bibliográficos
Autores principales: Lőrinczi, Bálint, Szatmári, István
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584415/
https://www.ncbi.nlm.nih.gov/pubmed/34769362
http://dx.doi.org/10.3390/ijms222111935
_version_ 1784597443893002240
author Lőrinczi, Bálint
Szatmári, István
author_facet Lőrinczi, Bálint
Szatmári, István
author_sort Lőrinczi, Bálint
collection PubMed
description Kynurenic acid (KYNA) is an endogenous neuroprotective agent of increasing importance. Several derivatives have already been synthesized, bearing an abundance of functional groups attached to the main skeleton in different positions. Several of these compounds have already been tested in biological evaluations, with several of them targeting the same receptors and biological effects as KYNA. However, these modified compounds build upon the unmodified KYNA skeleton leaving a possible route for the synthesis of new, potentially neuroprotective derivatives with heteroatom-containing ring systems. The aim of this review is to summarize the syntheses of KYNA derivatives with altered skeletons and to pinpoint an appealing transformation for future medicinal lead molecules.
format Online
Article
Text
id pubmed-8584415
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85844152021-11-12 KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect † Lőrinczi, Bálint Szatmári, István Int J Mol Sci Review Kynurenic acid (KYNA) is an endogenous neuroprotective agent of increasing importance. Several derivatives have already been synthesized, bearing an abundance of functional groups attached to the main skeleton in different positions. Several of these compounds have already been tested in biological evaluations, with several of them targeting the same receptors and biological effects as KYNA. However, these modified compounds build upon the unmodified KYNA skeleton leaving a possible route for the synthesis of new, potentially neuroprotective derivatives with heteroatom-containing ring systems. The aim of this review is to summarize the syntheses of KYNA derivatives with altered skeletons and to pinpoint an appealing transformation for future medicinal lead molecules. MDPI 2021-11-03 /pmc/articles/PMC8584415/ /pubmed/34769362 http://dx.doi.org/10.3390/ijms222111935 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lőrinczi, Bálint
Szatmári, István
KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect †
title KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect †
title_full KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect †
title_fullStr KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect †
title_full_unstemmed KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect †
title_short KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect †
title_sort kyna derivatives with modified skeleton; hydroxyquinolines with potential neuroprotective effect †
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584415/
https://www.ncbi.nlm.nih.gov/pubmed/34769362
http://dx.doi.org/10.3390/ijms222111935
work_keys_str_mv AT lorinczibalint kynaderivativeswithmodifiedskeletonhydroxyquinolineswithpotentialneuroprotectiveeffect
AT szatmariistvan kynaderivativeswithmodifiedskeletonhydroxyquinolineswithpotentialneuroprotectiveeffect